Single-blind RCT in 62 postmenopausal women with genitourinary syndrome of menopause: six weekly sessions of nonablative radiofrequency vs sham improved FSFI (mean change 5.86 vs 1.33) and Vaginal Health Index, sustained at 12 weeks; no adverse events.
RCTn = 62
Quezada-Bascuñán et al. Efficacy of nonablative radiofrequency on sexual function in postmenopausal women: a randomized clinical trial